News & Perspective

The study of VSV-EBOV hopes to enroll 6,000 health and other frontline workers.

The first two phase 1 trials of VSV-EBOV vaccine show good immune responses.

With its Mar 7 launch date, the trial's main goal is to see if ring vaccination can knock down Ebola hot spots.

An international team of experts says, in effect, "Don't be so sure" about Ebola not spreading by air.

The small biotech and the drug giant announced an agreement today.

MSF says the outbreak is not over and calls for rapid response teams for hot spots.

An efficacy trial could start in Liberia in December, according to WHO.

Experts today pushed for new ways to test Ebola treatments, and two groups renewed their urgent pleas for aid.

Senegal announced today the country's first Ebola virus disease case, in a student from Guinea who was located in a Dakar hospital.